Heart disease in sarcoidosis/ our experience

N. R. Vasic, V. Vucinic, V. Jelica, S. Ruza, V. Miodrag (Belgrade, Yugoslavia)

Source: Annual Congress 2003 - Sarcoidosis - extrathoracic manifestations and treatment
Session: Sarcoidosis - extrathoracic manifestations and treatment
Session type: Thematic Poster Session
Number: 1555
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. R. Vasic, V. Vucinic, V. Jelica, S. Ruza, V. Miodrag (Belgrade, Yugoslavia). Heart disease in sarcoidosis/ our experience. Eur Respir J 2003; 22: Suppl. 45, 1555

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Heart disease co-morbidity in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005

Who to treat/who not to treat: L Heart disease
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014


Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Pulmonary risk factors compromising post-operative recovery after open heart surgical repair of rheumatic heart disease - Philippine Heart Center Experience
Source: Eur Respir J 2005; 26: Suppl. 49, 393s
Year: 2005

Heart rate variability in patients with asthma and symptomatic hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 478s
Year: 2003

Heart failure and COPD: an ignored combination?
Source: Annual Congress 2008 - COPD – the holistic perspective
Year: 2008


Heart rate variability during the night in chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Heart rate variability during six-minute-walking test in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008



Heart failure and coronary artery disease in lung disease
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018


The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol
Source: Eur Respir J 2013; 41: 1017-1022
Year: 2013



Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease
Source: ERJ Open Res, 8 (1) 00460-2021; 10.1183/23120541.00460-2021
Year: 2022



Heart failure-COPD overlap and cardiovascular responses to exercise: a cardiologist’s perspective
Source: International Congress 2017 – ME6 Heart failure-COPD overlap and cardiovascular responses to exercise: a cardiologist’s perspective
Year: 2017


Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals
Source: Eur Respir Rev 2010 19: 272-278
Year: 2010



Spirometric changes in patients with rheumatic heart disease before and after mitral valve surgery at the Philippine Heart Center
Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing
Year: 2008


Radon and COPD mortality in the American Cancer Society Cohort
Source: Eur Respir J 2012; 39: 1113-1119
Year: 2012



Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020


Comparing the Comorbidity burden in Chronic Obstructive Pulmonary Disease and Heart Failure : evidence from a large population cohort
Source: International Congress 2019 – More and more COPD
Year: 2019

Is there a role of Heart Failure in pulmonary function testing?
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021